Medication info

Megagli 2 mg Tablets (Glymeperide)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202001916 · Approved 2020.03.19

This product's status changed to Approval withdrawn on 2024.09.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions given under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previous medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately ingesting sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was successfully managed initially. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Regular adjustment of the insulin dose based on blood glucose and glycated hemoglobin measurements is necessary. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with Type 2 diabetes
View approved original text

This medication is used to supplement dietary and exercise therapy to help control blood sugar levels in patients with Type 2 diabetes. It can be administered alone, and in cases where blood sugar control is difficult with oral hypoglycemics alone, it can be used in conjunction with insulin. Additionally, if blood sugar control is insufficient with sulfonylurea drugs or metformin monotherapy, it improves blood sugar control when used in combination with metformin. It is employed in various ways to more effectively manage patients' blood sugar levels.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is recommended to follow the instructions given under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. Consider the efficacy and duration of action of the previous medicine. 4) Dose monitoring While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately ingesting sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even if it was successfully managed initially. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and sometimes hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Regular adjustment of the insulin dose based on blood glucose and glycated hemoglobin measurements is necessary. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered with metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Patients who have had hypersensitivity reactions to this medicine, its components, or sulfonylurea drugs should avoid taking it. There is no experience with this drug in patients with severely impaired liver or kidney function, and switching to insulin treatment is recommended. Women who are pregnant, may become pregnant, or are breastfeeding should not use this medication. Patients with severe infections, before and after surgery, or with significant injuries should be treated with insulin for safety. Gastrointestinal disturbances such as diarrhea or vomiting may lead to inadequate absorption of food, raising the risk of hypoglycemia. This drug contains lactose, so patients with lactose intolerance or certain genetic metabolic disorders should not take it. During the first week of taking the medication, there is a higher risk of hypoglycemia, so blood sugar levels should be checked frequently. Elderly patients, those in poor nutritional status, or those who eat irregularly have a higher risk of hypoglycemia if exercise and diet are not balanced. Frequent alcohol consumption or skipping meals can also increase the risk of hypoglycemia. Patients with kidney or liver issues may be more sensitive to this medication, so caution is needed. The risk of hypoglycemia may also increase if there are other endocrine disorders or cases of overdose of this medication. When taken with certain medications like beta-blockers, symptoms of hypoglycemia may not present easily, so greater caution is required. Patients allergic to the yellow 4 component included in this medication should also use it cautiously. This medication can cause hypoglycemia, with symptoms of hypoglycemia including headache, severe hunger, nausea, fatigue, confusion, drowsiness, decreased consciousness, etc. In severe cases of hypoglycemia, loss of consciousness or seizures may occur, requiring immediate treatment. Short-term visual disturbances, such as blurry vision, may occur during initial dosing or when the blood sugar control status changes. Gastrointestinal discomfort including diarrhea and vomiting may arise, so caution is warranted. Liver function abnormalities may occur rarely; therefore, regular liver function tests are recommended. A serious side effect involving a decrease in blood cell count may occur rarely, so if abnormal symptoms arise, immediate consultation with a physician is necessary. Allergic reactions such as skin rashes, hives, or in severe cases, difficulty breathing or shock may occur, and if such symptoms appear, immediate cessation and hospital visit are required. During the course of taking this medication, any sudden adverse reactions or unexpected symptoms should be reported to healthcare professionals immediately. This medication requires regular intake along with dietary and exercise therapy to be effective, and monitoring of blood sugar control status should be steady. In case of hypoglycemia, it is advisable to immediately consume foods containing sugar to alleviate symptoms, so it's wise to always carry sugar. Particularly during stressful situations or surgery, and infections, blood sugar control may become challenging, requiring a switch to insulin treatment. Since this medication is primarily excreted by the kidneys, dosage adjustment is necessary for elderly patients or those with reduced kidney function. As interactions may occur when taken with other medications, it is important to inform healthcare professionals of any other medications being used. In cases of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment and treatment through glucose injections at a hospital. The safety and efficacy of this medication have not been established in children, so it is best to avoid use in this population. This medication should be stored out of the reach of children and kept in its original container to maintain its quality.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, reduced concentration, decreased agility or activity, depression, confusion, speech disturbances, aphasia, visual disturbances, tremors, incomplete paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cool and moist skin, tachycardia, hypertension, palpitations, angina, venous arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, cholestasis, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, skin photoreactions, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Also, avoid storing in excessively hot or cold areas, ideally keeping it at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.